These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 17261412)
21. Incidence of thrombosis after implantation of drug-eluting stents in patients with coronary artery disease. Chen JL; Yang YJ; Gao LJ; Huang JH; Qin XW; Qiao SB; Xu B; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Li JJ; Gao RL Chin Med J (Engl); 2008 Nov; 121(21):2144-7. PubMed ID: 19080174 [TBL] [Abstract][Full Text] [Related]
22. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798 [TBL] [Abstract][Full Text] [Related]
23. Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts. Okabe T; Lindsay J; Buch AN; Steinberg DH; Roy P; Slottow TL; Smith K; Torguson R; Xue Z; Satler LF; Kent KM; Pichard AD; Weissman NJ; Waksman R Am J Cardiol; 2008 Sep; 102(5):530-4. PubMed ID: 18721507 [TBL] [Abstract][Full Text] [Related]
24. Frequency of stent fracture as a cause of coronary restenosis after sirolimus-eluting stent implantation. Lee SH; Park JS; Shin DG; Kim YJ; Hong GR; Kim W; Shim BS Am J Cardiol; 2007 Aug; 100(4):627-30. PubMed ID: 17697818 [TBL] [Abstract][Full Text] [Related]
25. Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years. Ellis SG; Colombo A; Grube E; Popma J; Koglin J; Dawkins KD; Stone GW J Am Coll Cardiol; 2007 Mar; 49(10):1043-51. PubMed ID: 17349883 [TBL] [Abstract][Full Text] [Related]
26. Neointimal formation following drug-eluting stents: physiology, timeline, and the influence of drug delivery systems. Young JJ Rev Cardiovasc Med; 2007; 8 Suppl 1():S3-10. PubMed ID: 17401309 [TBL] [Abstract][Full Text] [Related]
27. Review of the TAXUS Liberté SR paclitaxel-eluting coronary stent. Ahmed WH Expert Rev Med Devices; 2007 Mar; 4(2):117-20. PubMed ID: 17359218 [TBL] [Abstract][Full Text] [Related]
29. Value and limitations of target-vessel ischemia in predicting late clinical events after drug-eluting stent implantation. Zellweger MJ; Kaiser C; Brunner-La Rocca HP; Buser PT; Osswald S; Weiss P; Mueller-Brand J; Pfisterer ME; J Nucl Med; 2008 Apr; 49(4):550-6. PubMed ID: 18344439 [TBL] [Abstract][Full Text] [Related]
30. Engineering aspects of stents design and their translation into clinical practice. Sangiorgi G; Melzi G; Agostoni P; Cola C; Clementi F; Romitelli P; Virmani R; Colombo A Ann Ist Super Sanita; 2007; 43(1):89-100. PubMed ID: 17536159 [TBL] [Abstract][Full Text] [Related]